The University Medical Center Groningen, formerly Groningen University Hospital, is the main hospital in Groningen, Netherlands. The medical centre is affiliated with the University of Groningen and offers supraregional tertiary care to the northern part of the Netherlands.

During the past decade, University Medical Center Groningen conducted 652 clinical trials. In the 10-year time frame, 652 clinical trials started and 122 clinical trials were completed, i.e. on average, 18.7% percent of trials that started reached the finish line to date. In the past 5 years, 287 clinical trials started and 82 clinical trials were completed. i.e. 28.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University Medical Center Groningen" #1 sponsor was "University Medical Center Groningen" with 341 trials, followed by "European Organisation for Research and Treatment of Cancer - EORTC" with 46 trials sponsored, "Children's Oncology Group" with 34 trials sponsored, "Radboud University Medical Center" with 30 trials sponsored and "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 30 trials sponsored. Other sponsors include 573 different institutions and companies that sponsored additional 293 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Medical Center Groningen" #1 collaborator was "University Medical Center Groningen" with 56 trials as a collaborator, "ZonMw: The Netherlands Organisation for Health Research and Development" with 42 trials as a collaborator, "National Cancer Institute (NCI)" with 38 trials as a collaborator, "Dutch Cancer Society" with 35 trials as a collaborator and "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 31 trials as a collaborator. Other collaborators include 1000 different institutions and companies that were collaborators in the rest 587 trials.

According to Clinical.Site data, the most researched conditions in "University Medical Center Groningen" are "Heart Failure" (31 trials), "Breast Cancer" (22 trials), "Atrial Fibrillation" (17 trials), "Leukemia" (17 trials) and "Multiple Myeloma" (17 trials). Many other conditions were trialed in "University Medical Center Groningen" in a lesser frequency.

Most popular intervention types in "University Medical Center Groningen" are "Drug" (544 trials), "Other" (166 trials), "Device" (130 trials), "Procedure" (115 trials) and "Biological" (82 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (98 trials), "radiation therapy" (27 trials), "cyclophosphamide" (24 trials), "vincristine sulfate" (22 trials) and "etoposide" (19 trials). Other intervention names were less common.

The vast majority of trials in "University Medical Center Groningen" are 938 trials for "All" genders, 73 trials for "Female" genders and 37 trials for "Male" genders.

Currently, there are 364 active trials in "University Medical Center Groningen". 11 are not yet recruiting, 228 are recruiting, 108 are Active, not recruiting, and 17 are Enrolling by invitation. In total, there were 483 completed trials in University Medical Center Groningen, 1 suspended trials, and 76 terminated clinical trials to date.

Out of the total trials that were conducted in University Medical Center Groningen, 113 "Phase 1" clinical trials were conducted, 233 "Phase 2" clinical trials and 270 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 58 trials, and there were also 215 trials that are defined as “Not Applicable".

University Medical Center Groningen has several departments that took part in Clinical trials: "Beatrix Children's Hospital, University Medical Center Groningen" - 18 trials